相关实验视频

Updated: Jul 13, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

探索HERV-K (HML-2) 对癌症的影响以及治疗干预的前景

Bárbara Costa^1,2,3, Nuno Vale^1,2,3

¹OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, s/n, 4200-450 Porto, Portugal.

International journal of molecular sciences

|October 14, 2023

概括

人体内源逆转录病毒 (HERVs),特别是HERV-K (HML-2),在癌症中发挥着关键作用. 研究正在探索HERV-K作为癌症治疗的潜在生物标志物和治疗点.

科学领域:

在瘤学瘤学.
病毒学病毒学
基因组学就是基因组学.

背景情况:

人体内源逆转录病毒 (HERVs) 是人类基因组中集成的古老逆转录病毒感染的遗留物.
特定的HERV家族,如HERV-K (HML-2),越来越多地与各种疾病病理有关,包括癌症.
了解HERV的作用对于开发新的治疗策略至关重要.

研究的目的:

审查目前对HERV参与癌症发展和进展的理解.
突出 HERV-K (HML-2) 作为潜在的癌症生物标志物和治疗点的重要性.
探索 HERV 相关研究的先进计算和系统生物学方法.

主要方法:

在瘤学中对HERV研究的文献综述.
对药物标结合的计算建模的分析.
对HERV-K动态的系统生物学模型的检查.
对抗HERV诱导疾病的抗病毒药物应用的审查.

主要成果:

HERVs,特别是 HERV-K (HML-2),与癌症的发病和进展密切相关.
计算和系统生物学方法为研究HERV-K提供了强大的工具.
抗病毒药物显示出对抗由HERVs驱动的疾病的潜力.
作为诊断生物标志物和治疗点,HERV-K显示出有前途.

结论:

HERV-K (HML-2) 代表了癌症研究和治疗的重要领域.
对HERV介导机制的进一步研究可以打开新的治疗途径.
计算和生物方法的整合是推动 HERV 向疗法的关键.

关键词:

在HERV-K (HML-2) 病毒中.抗病毒药物抗病毒药物癌症癌症癌症癌症癌症人类内源性逆转录病毒病毒感染病毒感染

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.